Search research articles
Contact Us
Filters
Showing results (321-330 of 667) with videos related to
Page
of 67
Sort By:
Science (New York, N.Y.)
|
February 27, 2016
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Davide Corti, John Misasi, Sabue Mulangu, et al.
Cell Reports
|
April 7, 2021
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base
Angela R Corrigan, Hongying Duan, Cheng Cheng, et al.
Cell Host & Microbe
|
March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies
Samantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
Nature
|
September 5, 2014
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface
Jinghe Huang, Byong H Kang, Marie Pancera, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2021
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants
Amarendra Pegu, Sarah O'Connell, Stephen D Schmidt, et al.
Immunity
|
May 8, 2025
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer
Fabian-Alexander Schleich, Shridhar Bale, Javier Guenaga, et al.
Cell Reports
|
August 7, 2020
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature
Cheng Cheng, Hongying Duan, Kai Xu, et al.
Cell Reports
|
December 15, 2024
A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies
Evan M Cale, Chen-Hsiang Shen, Adam S Olia, et al.
Scientific Reports
|
February 22, 2020
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
Li Ou, Wing-Pui Kong, Gwo-Yu Chuang, et al.
The Journal of Clinical Investigation
|
March 18, 2020
Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound
Evan M Cale, Hongjun Bai, Meera Bose, et al.
Page
of 67
Search research articles
Search
Showing results (321-330 of 667) with videos related to
Sort By:
Page
of 67
Science (New York, N.Y.)
|
February 27, 2016
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Davide Corti, John Misasi, Sabue Mulangu, et al.
Cell Reports
|
April 7, 2021
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base
Angela R Corrigan, Hongying Duan, Cheng Cheng, et al.
Cell Host & Microbe
|
March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies
Samantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
Nature
|
September 5, 2014
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface
Jinghe Huang, Byong H Kang, Marie Pancera, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2021
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants
Amarendra Pegu, Sarah O'Connell, Stephen D Schmidt, et al.
Immunity
|
May 8, 2025
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer
Fabian-Alexander Schleich, Shridhar Bale, Javier Guenaga, et al.
Cell Reports
|
August 7, 2020
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature
Cheng Cheng, Hongying Duan, Kai Xu, et al.
Cell Reports
|
December 15, 2024
A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies
Evan M Cale, Chen-Hsiang Shen, Adam S Olia, et al.
Scientific Reports
|
February 22, 2020
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
Li Ou, Wing-Pui Kong, Gwo-Yu Chuang, et al.
The Journal of Clinical Investigation
|
March 18, 2020
Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound
Evan M Cale, Hongjun Bai, Meera Bose, et al.
Page
of 67